The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nationwide incidence of sarcomas and tumors of intermediate malignancy in the NETSARC network with central pathology review: Correlation with published clinical research.
 
Gonzague De Pinieux
No Relationships to Disclose
 
Marie Karanian
No Relationships to Disclose
 
Francois Le Loarer
No Relationships to Disclose
 
Sophie Le Guellec
No Relationships to Disclose
 
Philippe Terrier
No Relationships to Disclose
 
Corinne Bouvier
No Relationships to Disclose
 
Maxime Battistella
No Relationships to Disclose
 
Yves Marie Robin
No Relationships to Disclose
 
Jean-François Emile
Honoraria - Amgen; Bristol-Myers Squibb; HalioDx; Merck Serono; MSD Oncology; Novartis; Pierre Fabre
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Anne Moreau
No Relationships to Disclose
 
Frederique Larousserie
No Relationships to Disclose
 
Agnès Leroux
No Relationships to Disclose
 
Nathalie Stock
No Relationships to Disclose
 
Marick Laé
No Relationships to Disclose
 
Françoise Collin
No Relationships to Disclose
 
Antoine Italiano
Honoraria - Bayer; Daiichi Sankyo; Epizyme; IPSEN; Lilly; Novartis; Roche
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Immune Design; Lilly; Roche
Research Funding - AstraZeneca/MedImmune; Bayer; Merck Serono; Merck Serono; MSD Oncology; PharmaMar; Roche
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
Axel Le Cesne
Honoraria - Bayer; Lilly; PharmaMar
 
Nicolas Penel
Research Funding - Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Jean Michel Coindre
No Relationships to Disclose
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Pharmamar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche